Synthesis of indolo[2,3-a]pyrrolo[3,4-c]carbazoles by oxidative cyclization of bisindolylmaleimides with a rhodium(III)-copper(II) catalytic system

Synthesis

Volumn , Issue 12, 2005, Pages 1959-1966

  Witulski, Bernhard ^a   Schweikert, Torsten ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Catalysis; Copper; Glycosides; Rebeccamycin; Rhodium

Indexed keywords

CATALYSIS; CATALYSTS; COPPER; METABOLITES; OXIDATION; RHODIUM; SYNTHESIS (CHEMICAL);

GLYCOSIDES; MOLECULAR OXYGEN; REBECCAMYCIN;

NITROGEN COMPOUNDS;

BISINDOLYLMALEIMIDE; CARBAZOLE DERIVATIVE; COPPER; FLUOROINDOLOCARBAZOLE; FLUOROTRYPTOPHANE; GLYCOSIDE; INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; REBECCAMYCIN; RHODIUM; TRYPTOPHAN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CATALYSIS; CHEMICAL STRUCTURE; CYCLIZATION; FEEDING; GLYCOSIDATION; MOLECULAR DYNAMICS; SYNTHESIS;

EID: 23744436958     PISSN: 00397881     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-869977     Document Type: Article

References (70)

1. For reviews on studies related to their chemistry and biology, see: (a) Bergman, J.; Janosik, T.; Wahlström, N. Adv. Heterocycl. Chem. 2001, 80, 1.
2. (b) Pindur, U.; Kim, Y.-S.; Mehrabani, F. Curr. Med. Chem. 1999, 6, 29.
3. (c) Gribble, G. W.; Berthel, S. J. Studies in Natural Product Chemistry, Vol. 12; Atta-ur-Rahman, Ed.; Elsevier Science Publishers: New York, 1993, 365.
4. (d) Knölker, H. J.; Reddy, K. R. Chem. Rev. 2002, 102, 4303.
5. (e) Steglich, W. Pure Appl. Chem. 1989, 61, 281.
6. (f) Prudhomme, M. Curr. Pharm. Des. 1997, 3, 265.
7. (g) Prudhomme, M. Curr. Med. Chem.: Anti-Cancer Agents 2004, 4, 509.
8. (a) Omura, S.; Iwai, Y.; Hirano, A.; Nakagawa, A.; Awaya, J.; Tsuchiya, H.; Takahashi, Y.; Masuma, R. J. Antibiot. 1977, 30, 275.
9. (b) Furusaki, A.; Hashiba, N.; Matsumoto, T. J. Chem. Soc., Chem. Commun. 1978, 800.
10. (c) Schupp, P.; Eder, C.; Proksch, P.; Wray, V. V.; Schneider, B.; Herderich, M.; Paul, V. J. Nat. Prod. 1999, 62, 959.
11. For total syntheses, see: (a) Link, J. T.; Raghavan, S.; Danishefsky, S. J. J. Am. Chem. Soc. 1995, 117, 552.
12. (b) Link, J. T.; Raghavan, S.; Gallant, M.; Chou, T. C.; Ballas, L. M.; Danishefsky, S. J. J. Am. Chem. Soc. 1996, 118, 2825.
13. (c) Wood, J. L.; Stoltz, B. M.; Goodman, S. N. J. Am. Chem. Soc. 1996, 118, 10656.
14. (d) Wood, J. L.; Stoltz, B. M.; Goodman, S. N.; Onwueme, K. J. Am. Chem. Soc. 1997, 119, 9652.
15. Omura, S.; Iwai, Y.; Hirano, A. Japan Kokai 7873,501, 1978; Chem. Abstr. 1978, 89, 178086h.
16. Oka, S.; Kodama, M.; Takeda, H.; Tomizuka, N.; Suzuki, H. Agric. Biol. Chem. 1986, 50, 2723.
17. (a) Hung, D. T.; Jamison, T. F.; Schreiber, S. L. Chem. Biol. 1996, 3, 623.
18. (b) Tamaoki, T.; Nomoto, H.; Takahashi, I.; Kato, Y.; Morimoto, M.; Tomita, F. Biochem. Biophys. Res. Commun. 1986, 135, 397.
19. (c) Yamada, S.; Hirota, K.; Chida, K.; Kuroki, T. Biochem. Biophys. Res. Commun. 1988, 157, 9.
20. (d) Fujita-Yamaguchi, Y.; Kathuria, S. Biochem. Biophys. Res. Commun. 1988, 157, 955.
21. (e) Sanchez-Martinez, C.; Shih, C.; Zhu, G.; Li, T.; Brooks, H. B.; Patel, B. K. R.; Schultz, R. M.; DeHahn, T. B.; Spencer, C. D.; Watkins, S. A.; Ogg, C. A.; Considine, E.; Dempsey, J. A.; Zhang, F. Bioorg. Med. Chem. Lett. 2003, 13, 3841.
22. (a) Bush, J. A.; Long, B. H.; Cationo, J. J.; Bradner, W. T.; Tomita, K. J. Antibiot. 1987, 40, 668.
23. (b) Nettleton, D. E.; Doyle, T. W.; Krishnan, B.; Matsumoto, G. K.; Clardy, J. Tetrahedron Lett. 1985, 26, 4011.
24. (c) Pommier, Y. Curr. Med. Chem.: Anti-Cancer Agents 2004, 4, 429.
25. (d) Voldoire, A.; Moreau, P.; Sancelme, M.; Matulova, M.; Léonce, S.; Pierré, A.; Hickman, J.; Pfeiffer, B.; Renard, P.; Dias, N.; Bailly, C.; Prudhomme, M. Bioorg. Med. Chem. 2004, 12, 1955.
26. (e) Woo, M. H.; Vance, J. R.; Otero Marcos, A. R.; Bailly, C.; Bjornsti, M.-A. J. Biol. Chem. 2002, 277, 3813.
27. (f) Moreau, P.; Anizon, F.; Sancelme, M.; Prudhomme, M.; Sevère, D.; Riou, J.-F.; Goossens, J.-F.; Hénichart, J.-P.; Bailly, C.; Labourier, E.; Tazzi, J.; Fabbro, D.; Meyer, T.; Aubertin, A. M. J. Med. Chem. 1999, 42, 1816.
28. (g) Bailly, C.; Riou, J.-F.; Colson, P.; Houssier, C.; Rodrigues-Pereira, E.; Prudhomme, M. Biochemistry 1997, 36, 3917.
29. (h) Faul, M. M.; Sullivan, K. A.; Grutsch, J. L.; Winneroski, L. L.; Shih, C.; Sanchez-Martinez, C.; Cooper, J. T. Tetrahedron Lett. 2004, 45, 1095.
30. For total syntheses of rebeccamycin, see: (a) Kaneko, T.; Wong, H.; Okamoto, K. T.; Clardy, J. Tetrahedron Lett. 1985, 26, 4015.
31. (b) Gallant, M.; Link, J. T.; Danishefsky, S. J. J. Org. Chem. 1993, 58, 343.
32. (c) Faul, M. M.; Winneroski, L. L.; Krumrich, C. A. J. Org. Chem. 1999, 64, 2465.
33. Lam, K. S.; Schroeder, D. R.; Veitch, J. M.; Colson, K. L.; Matson, J. A.; Rose, W. C.; Doyle, T. W.; Forenza, S. J. Antibiot. 2001, 54, 1.
34. Long, B. H.; Rose, W. C.; Vyas, D. M.; Matson, J. A.; Forenza, S. Curr. Med. Chem.: Anti-Cancer Agents 2002, 2, 255.
35. For the assembly of indolo[2,3-a]carbazoles via metalation-cross-coupling sequences, see: Cai, X.; Snieckus, V. Org. Lett. 2004, 6, 2293.
36. For the assembly of indolo[2,3-a]carbazoles via Pd-mediated endo-dig cyclizations, see: Saulnier, M. G.; Frennesson, D. B.; Deshpande, M. S.; Vyas, D. M. Tetrahedron Lett. 1995, 36, 7841.
37. For the assembly of indolo[2,3-a]carbazoles via chromium carbene complexes, see: Merlic, C. A.; McInnes, D. M.; You, Y. Tetrahedron Lett. 1997, 38, 6787.
38. For the assembly of indolo[2,3-a]carbazoles by Diels-Alder reactions, see: (a) Kuethe, J. T.; Davies, I. W. Tetrahedron Lett. 2004, 45, 4009.
39. (b) Pindur, U.; Kim, M.-H. Arch. Pharm. 1992, 325, 353.
40. (c) Nomak, R.; Snyder, J. K. Tetrahedron Lett. 2001, 42, 7929.
41. (d) Barry, J. F.; Wallace, T. W.; Walshe, N. D. A. Tetrahedron 1995, 47, 12797.
42. For approaches to the indolo[2,3-a]carbazole ring system by double Fischer indolizations, see: (a) Bergman, J.; Pelcman, B. J. Org. Chem. 1989, 54, 824.
43. (b) Gribble, G. W.; Berthel, S. J. Tetrahedron 1992, 48, 8869.
44. (a) Link, J. T.; Gallant, M.; Danishefsky, S. J.; Huber, S. Tetrahedron Lett. 1994, 35, 5555.
45. (b) Beccalli, E. M.; Gelmi, M. L.; Marchesini, A. Tetrahedron 1998, 54, 6909.
46. (c) Eils, S.; Winterfeldt, E. Synthesis 1999, 275.
47. (d) Routier, S.; Coudert, G.; Mérour, J.-Y.; Caignard, D. H. Tetrahedron Lett. 2002, 43, 2561.
48. (e) Reddy, G. M.; Chen, S.-Y.; Uang, B.-J. Synthesis 2003, 497.
49. (f) Sanchez-Martinez, C.; Faul, M. M.; Shih, C.; Sullivan, K. A.; Grutsch, J. L.; Cooper, J. T.; Kolis, S. P. J. Org. Chem. 2003, 68, 8008.
50. (a) Joyce, R. P.; Gainor, J. A.; Weinreb, S. M. J. Org. Chem. 1987, 52, 1177.
51. (b) Kleinschroth, J.; Hartenstein, J.; Rudolph, C.; Schächtele, C. Bioorg. Med. Chem. Lett. 1995, 5, 55.
52. (c) Chisholm, J. D.; Van Vranken, D. L. J. Org. Chem. 2000, 65, 7541.
53. (d) Zhu, G.; Conner, S. E.; Zhou, X.; Shih, C.; Li, T.; Anderson, B. D.; Brooks, H. B.; Campbell, R. M.; Considine, E.; Dempsey, J. A.; Faul, M. M.; Ogg, C.; Patel, B.; Schultz, R. M.; Spencer, C. D.; Teicher, B.; Watkins, S. A. J. Med. Chem. 2003, 46, 2027.
54. Faul, M. M.; Sullivan, K. A. Tetrahedron Lett. 2001, 42, 3271.
55. (a) Harris, W.; Hill, C. H.; Keech, E.; Malsher, P. Tetrahedron Lett. 1993, 34, 8361.
56. (b) Beccalli, E. M.; Gelmi, M. L.; Marchesini, A. Tetrahedron 1998, 54, 6909.
57. Ohkubo, M.; Nishimura, T.; Jona, H.; Honma, T.; Morishima, H. Tetrahedron 1996, 52, 8099.
58. (a) Ohkubo, M.; Kawamoto, H.; Ohno, T.; Nakano, M.; Morishima, H. Tetrahedron 1997, 53, 585.
59. (b) Zembower, D. E.; Zhang, H.; Lineswala, J. P.; Kuffel, M. J.; Aytes, S. A.; Ames, M. M. Bioorg. Med. Chem. Lett. 1999, 9, 145.
60. Ohkubo, M.; Nishimura, T.; Jona, H.; Honma, T.; Ito, S.; Morishima, H. Tetrahedron 1997, 53, 5937.
61. Wang, J.; Rosingana, M.; Watson, D. J.; Dowdy, E. D.; Discordia, R. P.; Soundarajan, N.; Li, W.-S. Tetrahedron Lett. 2001, 42, 8935.
62. (a) Steglich, W.; Steffan, B.; Kopanski, L.; Eckhardt, G. Angew. Chem., Int. Ed. Engl. 1980, 19, 459.
63. (b) Brenner, M.; Rexhausen, H.; Steffan, B.; Steglich, W. Tetrahedron 1988, 44, 2887.
64. Grushin, V. V.; Marshall, W. J.; Thorn, D. L. Adv. Synth. Catal. 2001, 343, 161.
65. (a) Kalinovskii, I. O.; Lescheva, A. A.; Kuteinikova, M. M.; Gel'bshtein, A. I. Zh. Obshch. Khim. 1990, 60, 123;
66. J. Gen. Chem. USSR (Engl. Transl.), 1990, 60, 108.
67. (b) Leshcheva, A. A.; Kalinovskii, I. O.; Pogorelov, V. V.; Noskov, Y. G.; Gel'bshtein, A. I. Kin. Katal. 1998, 39, 354.
68. Choi, D.-S.; Huang, S.; Huang, M.; Barnard, T. S.; Adams, R. D.; Seminario, J. M.; Tour, J. M. J. Org. Chem. 1998, 63, 2646.
69. Bergman, J.; Koch, E.; Pelcman, B. J. Chem. Soc., Perkin Trans. 1 2000, 2609.
70. When this manuscript was in preparation, we became aware of a recent report on the design, synthesis and biological evaluation of a set of fluoroindolocarbazole glycosides including compound 3 as very selective topoisomerase I active agents. However, no experimental details were given: Balasubramanian, B. N.; St. Laurent, D. R.; Saulnier, M. G.; Long, B. H.; Bachand, C.; Beaulieu, F.; Clarke, W.; Deshpande, M.; Eummer, J.; Fairchild, C. R.; Frennesson, D. B.; Kramer, R.; Lee, F. Y.; Mahler, M.; Martel, A.; Naidu, B. N.; Rose, W. C.; Russell, J.; Ruediger, E.; Solomon, C.; Stoffan, K. M.; Wong, H.; Zimmermann, K.; Vyas, D. M. J. Med. Chem. 2004, 47, 1609.